BioMarin Rolls Out $4B Revenue Expectations, as Analysts Wonder About Pipeline

BioMarin executives sought to calm an anxious investor base Wednesday with a public address and pledge to achieve a nearly 50% bump in annual revenue by 2027. But analysts were left wanting.